WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

OBJECTIVE: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, there are still few data in hematologic patients. Some small studies have shown a high mortality on patients with hematologic malignancies and COVID-19. In this study we aim to report a single center e...

Descripción completa

Detalles Bibliográficos
Autores principales: ERDEM, Simge, MASTANZADE, Metban, OZBALAK, Mustafa Murat, EKINCI, Sevda SERT, OZLUK, Dilek Ozden, TIRYAKI, Tarık Onur, OLUK, Beyza, HINDILERDEN, Ipek YONAL, YENEREL, Mustafa Nuri, NALCACI, Meliha, TUKEK, Tufan, BESISIK, Sevgi KALAYOGLU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2021
Materias:
Pp 53
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572565/
http://dx.doi.org/10.1016/j.htct.2021.10.1063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572565/
http://dx.doi.org/10.1016/j.htct.2021.10.1063

Ejemplares similares